Its no wonder that, since this new class of appetite-curbing GLP-1 medications, including Ozempic, Wegovy, and Zepbound, burst into public consciousness, nearly $1 billion of venture capital dollars have been injected into the growing sector of weight-loss companies, which is now awash with startups prescribing the drugs, according to PitchBook data from the last year and a half
Some patients participate for several months, while others may continue longer depending on their goals, progress, and provider recommendations
The FDA has not looked at how safe these salt versions are or how well they work
This effect translated into projected cost savings of 213,662,133 at the base case 10-year time horizon, Table 1 and Table S7
Both the Wegovy pill and Rybelsus are oral semaglutide tablets, so they contain the same active ingredient, but they are licensed for different reasons and use different doses